Remmel H. Lawrence 4
4 · ATOSSA THERAPEUTICS, INC. · Filed Mar 28, 2025
Insider Transaction Report
Form 4
Remmel H. Lawrence
Director
Transactions
- Purchase
Common Stock
2025-03-26$0.70/sh+10,000$7,000→ 10,257 total
Footnotes (1)
- [F1]Reflects a reverse stock split of the Issuer's common stock at a ratio of 12:1 effective April 2018. The Reporting Person disclaims beneficial ownership of 11 shares of common stock owned by his spouse except to the extent of his pecuniary interest in the shares.